Using RE-AIM to evaluate the implementation of a social marketing and free product distribution project for fentanyl and xylazine test strips in New York State
Abstract Background Drug test strips can be used to check for the presence of contaminants, such as fentanyl and xylazine in a person’s drug supply. In 2022, New York State began a media campaign and free drug test strip distribution effort throughout the state to raise awareness of adulterated drug...
Saved in:
| Main Authors: | Hilary M. Kirk, Joshua J. Lynch, Kimberly A. Bernosky, Orian B. Painter, Shelby Arena, Mia Dickinson, Lyudmila Pakhomova, Brian M. Clemency |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2025-06-01
|
| Series: | Harm Reduction Journal |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s12954-025-01259-z |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Xylazine prevalence and concentration in the Los Angeles fentanyl market, 2023–2025
by: Joseph Friedman, et al.
Published: (2025-09-01) -
Opioid‐related xylazine toxicity manifesting as myonecrosis, rhabdomyolysis, multifocal ischemic cerebral infarcts, and cerebral edema
by: Ogechi Nwodim, et al.
Published: (2024-06-01) -
Heroin or fentanyl: Prevalence of confirmed fentanyl in ED patients with suspected heroin overdose
by: Siri Shastry, et al.
Published: (2024-08-01) -
Community-based drug checking at syringe service programs in New York City observe an increasing prevalence of xylazine from 2021 through 2024
by: Leonardo A. Dominguez Gomez, et al.
Published: (2025-06-01) -
Psychosocial consequences of xylazine and implications for harm reduction services
by: Marina Plesons, et al.
Published: (2025-09-01)